Total Payments
$8,399
2024 Payments
$669.45
Companies
45
Transactions
591
Medicare Patients
3,194
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$7,551 (89.9%)
Other$661.65 (7.9%)
Research$125.00 (1.5%)
Education$61.29 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,551 | 578 | 89.9% |
| Honoraria | $525.00 | 1 | 6.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $136.65 | 1 | 1.6% |
| Unspecified | $125.00 | 1 | 1.5% |
| Education | $61.29 | 10 | 0.7% |
Payments by Type
General
$8,274
590 transactions
Research
$125.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,035 | 85 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $967.95 | 65 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $658.82 | 55 | $0 (2021) |
| PROTEGA PHARMACEUTIALS INC | $642.62 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $618.22 | 50 | $0 (2024) |
| Indivior Inc. | $586.95 | 26 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $423.12 | 32 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $402.26 | 24 | $0 (2017) |
| PFIZER INC. | $364.26 | 38 | $0 (2021) |
| Lilly USA, LLC | $354.15 | 26 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $669.45 | 13 | PROTEGA PHARMACEUTIALS INC ($642.62) |
| 2023 | $13.86 | 1 | Indivior Inc. ($13.86) |
| 2022 | $82.84 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($43.93) |
| 2021 | $616.44 | 52 | Collegium Pharmaceutical, Inc. ($157.20) |
| 2020 | $530.91 | 42 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($137.53) |
| 2019 | $2,190 | 166 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($360.60) |
| 2018 | $1,593 | 123 | Novo Nordisk Inc ($342.44) |
| 2017 | $2,702 | 188 | Novo Nordisk Inc ($464.13) |
All Payment Transactions
591 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | PROTEGA PHARMACEUTIALS INC | — | Honoraria | Cash or cash equivalent | $525.00 | General |
| 10/22/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Pain Management | ||||||
| 10/15/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Pain Management | ||||||
| 10/08/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Pain Management | ||||||
| 10/01/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: Pain Management | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Gastroenterology | ||||||
| 08/20/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Pain Management | ||||||
| 06/04/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Pain Management | ||||||
| 04/16/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Pain Management | ||||||
| 03/26/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Pain Management | ||||||
| 03/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Pain Management | ||||||
| 02/01/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Pain Management | ||||||
| 12/07/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: OUD | ||||||
| 11/16/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: DIABETES | ||||||
| 08/12/2022 | USWM, LLC | Lucemyra (Drug), ZIMHI | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Psychiatry/Psychology | ||||||
| 05/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DIABETES | ||||||
| 03/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Gastroenterology | ||||||
| 02/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: DIABETES | ||||||
| 12/14/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Chronic Pain | ||||||
| 12/09/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 11/30/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: Opioid Analgesic | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information | Indivior Inc. | $125.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 631 | 3,499 | $1.2M | $285,773 |
| 2022 | 16 | 778 | 3,495 | $1.2M | $290,503 |
| 2021 | 17 | 853 | 3,716 | $1.1M | $256,565 |
| 2020 | 16 | 932 | 3,759 | $1.1M | $234,319 |
Total Patients
3,194
Total Services
14,469
Medicare Billing
$1.1M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 234 | 1,885 | $754,000 | $204,978 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 201 | 838 | $293,300 | $64,091 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $19,600 | $7,047 | 36.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 91 | 520 | $130,000 | $6,321 | 4.9% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 19 | 36 | $5,400 | $1,810 | 33.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 116 | $6,960 | $1,458 | 20.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 55 | $2,750 | $68.17 | 2.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 1,681 | $672,400 | $188,308 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 834 | $291,900 | $65,595 | 22.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 77 | 446 | $111,500 | $5,540 | 5.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 29 | 90 | $9,000 | $4,542 | 50.5% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2022 | 56 | 83 | $12,450 | $4,208 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $11,200 | $4,099 | 36.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 16 | 16 | $8,000 | $3,755 | 46.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $10,150 | $2,603 | 25.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 16 | 16 | $12,400 | $2,352 | 19.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 16 | 53 | $3,975 | $2,219 | 55.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 15 | 15 | $7,500 | $2,089 | 27.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 13 | 13 | $10,100 | $2,026 | 20.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 33 | $7,700 | $1,650 | 21.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 90 | $5,400 | $1,180 | 21.8% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 12 | 13 | $600.00 | $260.91 | 43.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 15 | 55 | $2,750 | $75.52 | 2.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 195 | 1,307 | $522,800 | $146,566 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 183 | 827 | $289,450 | $64,274 | 22.2% |
About Dr. Sarath Babu, MD
Dr. Sarath Babu, MD is a Internal Medicine healthcare provider based in East Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992744767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarath Babu, MD has received a total of $8,399 in payments from pharmaceutical and medical device companies, with $669.45 received in 2024. These payments were reported across 591 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($7,551).
As a Medicare-enrolled provider, Babu has provided services to 3,194 Medicare beneficiaries, totaling 14,469 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location East Brunswick, NJ
- Active Since 06/06/2006
- Last Updated 01/04/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992744767
Products in Payments
- FARXIGA (Drug) $833.31
- XTAMPZA (Drug) $504.64
- JARDIANCE (Drug) $438.05
- XIFAXAN (Drug) $419.58
- TRULANCE (Drug) $344.47
- Victoza (Drug) $297.77
- SUBLOCADE (Drug) $253.54
- Tresiba (Drug) $246.63
- TRULICITY (Drug) $211.41
- SUBOXONE SUBLINGUAL FILM (Drug) $208.41
- XYOSTED (Drug) $186.98
- XIFAXANIBSD (Drug) $186.62
- Saxenda (Drug) $175.06
- Ozempic (Drug) $168.86
- CHANTIX (Drug) $156.42
- JANUVIA (Drug) $148.39
- SUBOXONE (Drug) $125.00
- Movantik (Drug) $121.08
- ROXYBOND (Drug) $117.62
- Nucynta (Drug) $117.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Brunswick
David Schaer, Md, MD
Internal Medicine — Payments: $92,124
Internal Medicine $92,124
Aamer Farooq, Md, MD
Internal Medicine — Payments: $19,081
Internal Medicine $19,081
Dr. Lev Simkhayev, M.d, M.D
Internal Medicine — Payments: $11,458
Internal Medicine $11,458
Dr. Ahab Gabriel
Internal Medicine — Payments: $8,656
Internal Medicine $8,656
Scott Yager, M.d, M.D
Internal Medicine — Payments: $8,091
Internal Medicine $8,091
Jenny Liu, Md, Ms, MD, MS
Internal Medicine — Payments: $7,952
Internal Medicine $7,952